Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Protocole HAART")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2969

  • Page / 119
Export

Selection :

  • and

Predictors of Success with Highly Active Antiretroviral Therapy in an Antiretroviral-Naive Urban PopulationZARAGOZA-MACIAS, Elisa; COSCO, Dominique; MINH LY NGUYEN et al.AIDS research and human retroviruses. 2010, Vol 26, Num 2, pp 133-138, issn 0889-2229, 6 p.Article

The Association Between Primary Antiretroviral Resistance and HAART Virologic Failure in a Developing SetHENRIQUE GAGLIANI, Luiz; ALKMIM MAIA, Wagner T; SA-FILHO, Dercy et al.AIDS research and human retroviruses. 2011, Vol 27, Num 3, pp 251-256, issn 0889-2229, 6 p.Article

Variation of CD4 Count and Percentage during Pregnancy and after Delivery : Implications for HAART Initiation in Resource-Limited SettingsEKOUEVI, Didier K; INWOLEY, André; TONWE-GOLD, Besigin et al.AIDS research and human retroviruses. 2007, Vol 23, Num 12, pp 1469-1473, issn 0889-2229, 5 p.Article

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapyBREEN, Ronan. A. M; MILLER, R. F; GORSUCH, T et al.The Journal of infectious diseases. 2006, Vol 193, Num 10, pp 1437-1440, issn 0022-1899, 4 p.Article

Impact of pre-therapy viral load on virological response to modern first-line HAARTSANTORO, Maria Mercedes; ARMENIA, Daniele; FORBID, Federica et al.Antiviral therapy (London). 2013, Vol 18, Num 7, pp 867-876, issn 1359-6535, 10 p.Article

Beyond virological suppression: the role of adherence in the late HAART eraAMMASSARI, Adriana; TROTTA, Maria Paola; SHALEV, Noga et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 785-792, issn 1359-6535, 8 p.Article

The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapyWILLIAMS, M; CLARKE, T; WILLIAMS, P et al.West indian medical journal. 2007, Vol 56, Num 3, pp 270-274, issn 0043-3144, 5 p.Article

Short-Term Discontinuation of HAART Regimens More Common in Vulnerable Patient PopulationsROBISON, Lindsay S; WESTFALL, Andrew O; MUGAVERO, Michael J et al.AIDS research and human retroviruses. 2008, Vol 24, Num 11, pp 1347-1355, issn 0889-2229, 9 p.Article

Implications of X4 tropic virus detection before HAART and disease progressionANSARI, Aftab A.AIDS (London). 2008, Vol 22, Num 4, pp 533-534, issn 0269-9370, 2 p.Article

Immunological Rebound after Initiation of Highly Active Antiretroviral Therapy in Treatment-Naive PatientsBLACKARD, Jason T; WELLES, Seth L; ACKERMAN, Avra et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 499-504, issn 0889-2229, 6 p.Article

Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3TOULSON, Adrienne R; HARRIGAN, Richard; HEATH, Katherine et al.The Journal of infectious diseases. 2005, Vol 192, Num 10, pp 1787-1793, issn 0022-1899, 7 p.Article

Increased Resilience to the Development of Drug Resistance with Modem Boosted Protease Inhibitor-Based Highly Active Antiretroviral TherapyLIMA, Viviane D; GILL, Vikram S; YIP, Benita et al.The Journal of infectious diseases. 2008, Vol 198, Num 1, pp 51-58, issn 0022-1899, 8 p.Article

Long-term observation of adolescents initiating HAART therapy : Three-year follow-upFLYNN, Patricia M; RUDY, Bret J; D'ANGELO, Lawrence et al.AIDS research and human retroviruses. 2007, Vol 23, Num 10, pp 1208-1214, issn 0889-2229, 7 p.Article

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: Results from the EuroSIDA study groupMOCROFT, A; LEDERGERBER, B; VIARD, J. P et al.The Journal of infectious diseases. 2004, Vol 190, Num 11, pp 1947-1956, issn 0022-1899, 10 p.Article

Long-term immunologic outcome in HAART-experienced subjects receiving lopinavir/ritonavirBONGIOVANNI, Marco; BINI, Teresa; CASANA, Maddalena et al.AIDS research and human retroviruses. 2006, Vol 22, Num 11, pp 1099-1105, issn 0889-2229, 7 p.Article

Nucleoside analogue use before and during highly active antiretroviral therapy and virus load reboundThe Journal of infectious diseases. 2004, Vol 190, Num 4, pp 675-687, issn 0022-1899, 13 p.Article

Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence LevelLIMA, Viviane D; BANGSBERG, David R; HARRIGAN, P. Richard et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 4, pp 460-465, issn 1525-4135, 6 p.Article

Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project MalawiORLANDO, Stefano; MARAZZI, Maria Cristina; MANCINELLI, Sandro et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 5, pp 631-634, issn 1525-4135, 4 p.Article

When to initiate highly active antiretroviral therapy in low-resource settings : the Moroccan experienceLOUBIERE, Sandrine; KAMAL MARHOUM EL FILAL; SODQI, Mustapha et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 241-251, issn 1359-6535, 11 p.Article

Chinese Pediatric Highly Active Antiretroviral Therapy Observational Cohort : A 1-Year Analysis of Clinical, Immunologic, and Virologic OutcomesFUJIE ZHANG; HABERER, Jessica E; YAN ZHAO et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 5, pp 594-598, issn 1525-4135, 5 p.Article

The good, the bad, and the ugly : Providing highly active antiretroviral therapy when it is most difficultFLANIGAN, Timothy P; MITTY, Jennifer A.Clinical infectious diseases. 2006, Vol 42, Num 11, pp 1636-1638, issn 1058-4838, 3 p.Article

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes : Expression of archival virus and replication of virusTOBIN, Nicole H; LEARN, Gerald H; FRENKEL, Lisa M et al.Journal of virology. 2005, Vol 79, Num 15, pp 9625-9634, issn 0022-538X, 10 p.Article

Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?GOMPELS, Mark; DUNN, David T; JOHNSON, Margaret et al.The Journal of infectious diseases. 2012, Vol 205, Num 4, pp 540-547, issn 0022-1899, 8 p.Article

Beneficial Effects of a Switch to a Lopinavir/ritonavir-Containing Regimen for Patients with Partial or No Immune Reconstitution with Highly Active Antiretroviral Therapy Despite Complete Viral SuppressionPITRAK, D. L; ESTES, R; NOVAK, R. M et al.AIDS research and human retroviruses. 2011, Vol 27, Num 6, pp 659-667, issn 0889-2229, 9 p.Article

Decreasing soluble CD30 and increasing IFN-γ plasma levels are indicators of effective highly active antiretroviral therapySADEGHI, Mahmoud; SÜSAL, Caner; DANIEL, Volker et al.AIDS research and human retroviruses. 2007, Vol 23, Num 7, pp 886-890, issn 0889-2229, 5 p.Article

  • Page / 119